Current advancement in radiation therapy for uterine cervical cancer. 2010

Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
Department of Radiation Oncology, Gunma University Graduate school of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, Japan. tnakano@med.gunma-u.ac.jp

Radiation therapy is one of the effective curative treatments for uterine cervical cancer. However poor clinical results for the advanced stages require further improvement of the treatment. Intensive studies on basic and clinical research have been made to improve local control, primarily important for long term survival in radiation therapy. Regarding current advancement in radiation therapy for uterine cervical cancer, the following three major subjects are pointed out; technological development to improve dose distribution by image guided radiation therapy technology, the concomitant anticancer chemotherapy with combination of radiation therapy, and radiation biological assessment of the radiation resistance of tumors. The biological factors overviewed in this article include hypoxia relating factors of HIF-1alpha, SOD, cell cycle parameters of pMI, proliferation factors of Ki67, EGFR, cerbB2, COX-2, cycle regulation proteins p53, p21, apoptosis regulation proteins Bcl2 and Bax and so on. Especially, the variety of these radiation biological factors is important for the selection of an effective treatment method for each patient to maximize the treatment benefit.

UI MeSH Term Description Entries
D011881 Radiotherapy, Computer-Assisted Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients. Computer-Assisted Radiotherapy,Radiation Therapy, Computer-Assisted,Computer-Assisted Radiation Therapy,Computer Assisted Radiation Therapy,Computer Assisted Radiotherapy,Computer-Assisted Radiation Therapies,Computer-Assisted Radiotherapies,Radiation Therapies, Computer-Assisted,Radiation Therapy, Computer Assisted,Radiotherapies, Computer-Assisted,Radiotherapy, Computer Assisted,Therapies, Computer-Assisted Radiation,Therapy, Computer-Assisted Radiation
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003952 Diagnostic Imaging Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. Imaging, Diagnostic,Imaging, Medical,Medical Imaging
D005260 Female Females
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015336 Molecular Probe Techniques The use of devices which use detector molecules to detect, investigate, or analyze other molecules, macromolecules, molecular aggregates, or organisms. Molecular Probe Technic,Molecular Probe Technics,Molecular Probe Technique,Technic, Molecular Probe,Technics, Molecular Probe,Technique, Molecular Probe,Techniques, Molecular Probe,Probe Technic, Molecular,Probe Technics, Molecular,Probe Technique, Molecular,Probe Techniques, Molecular
D020266 Radiotherapy, Conformal A therapy using IONIZING RADIATION where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators. Conformal Radiotherapy,3-D Conformal Radiotherapy,Three-Dimensional Conformal Radiotherapy,3-D Conformal Radiotherapies,Conformal Radiotherapies,Conformal Radiotherapies, 3-D,Conformal Radiotherapies, Three-Dimensional,Conformal Radiotherapy, 3-D,Conformal Radiotherapy, Three-Dimensional,Radiotherapies, 3-D Conformal,Radiotherapies, Conformal,Radiotherapies, Three-Dimensional Conformal,Radiotherapy, 3-D Conformal,Radiotherapy, Three-Dimensional Conformal,Three Dimensional Conformal Radiotherapy,Three-Dimensional Conformal Radiotherapies

Related Publications

Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
August 2019, Archives of gynecology and obstetrics,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
January 2018, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
January 2019, In vivo (Athens, Greece),
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
October 2013, Gynecologic oncology,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
January 2012, Oncology,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
September 2015, Anticancer research,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
February 2022, Gan to kagaku ryoho. Cancer & chemotherapy,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
May 1960, Missouri medicine,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
June 1961, Clinical obstetrics and gynecology,
Takashi Nakano, and Tatsuya Ohno, and Hitoshi Ishikawa, and Yoshiyuki Suzuki, and Takeo Takahashi
June 1961, La Clinica ostetrica e ginecologica,
Copied contents to your clipboard!